An innovative experimental treatment for boosting the effectiveness of blood stem-cell transplants with umbilical cord blood has a favorable safety profile in long-term animal studies, according to Harvard Stem Cell Institute (HSCI) scientists at Dana-Farber Cancer Institute (DFCI), Beth Israel Deaconess Medical Center (BIDMC), and [Continue]
In a study of human tumors growing in mice, University of Minnesota researchers have found that immune cells derived from human embryonic stem cells (hESCs) completely eliminated the tumors in 100 percent of mice tested. These new killer cells could help develop cures for leukemia, lymphoma, prostate cancer, breast cancer and testicular cancer. [Continue]
In a study of human tumors growing in mice, University of Minnesota researchers have found that immune cells derived from human embryonic stem cells (hESCs) completely eliminated the tumors in 100 percent of mice tested. These new killer cells could help develop cures for leukemia, lymphoma, prostate cancer, breast cancer and testicular cancer. [Continue]
